Literature DB >> 25677098

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.

Carlo Saitta1, Gianluca Tripodi2, Adalberto Barbera3, Antonio Bertuccio2, Antonina Smedile4, Alessia Ciancio4, Giuseppina Raffa1, Angelo Sangiovanni5, Giuseppe Navarra3, Giovanni Raimondo1,2, Teresa Pollicino1,6.   

Abstract

BACKGROUND & AIMS: Hepatitis B virus (HBV) DNA integration in the host genome is a major mechanism responsible for the etiopathogenetic role exerted by HBV in hepatocellular carcinoma (HCC) development. Extensive analyses evaluating viral integration in HBV surface antigen (HBsAg) negative patients with occult HBV infection (OBI) have not yet been performed. The aim of this study was to investigate and characterize HBV DNA integration in HCC tissues from OBI patients.
METHODS: Tumour DNA extracts from 69 HCC patients (49 HBsAg-negative with occult infection diagnosed by HBV DNA detection in tumour tissues; 10 HBsAg-positive and 10 HBsAg-negative/OBI-negative as control groups) were examined by Alu-PCR technique to reveal HBV DNA integration into the host genome. The molecular characterization of the virus-genome junctions was performed by cloning and sequencing analyses.
RESULTS: Integrated HBV DNA was detected in 37/49 (75.5%) OBI-positive HCC samples, in 8/10 (80%) HBsAg-positive and in 0/10 OBI-negative HCC samples. Nine of 37 (24.3%) integrated viral sequences from OBI-positive cases were inside human genome coding regions and in the remaining cases the localization at intergenic level was frequently adjacent to coding genes. Concerning viral integrants in OBI cases, X gene sequences were found in 14 cases, preS/S sequences in 13, Core sequences in 7, and Polymerase gene sequences in three cases.
CONCLUSIONS: In analogy to what occurs in HBsAg-positive cases, HBV DNA integration is highly prevalent in OBI-related HCCs, it mainly involves X and preS/S viral genomic regions and it frequently occurs at the level of regulatory and functional genes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alu-PCR; HBV DNA; HBsAg-negative; HCC; viral integrants

Mesh:

Substances:

Year:  2015        PMID: 25677098     DOI: 10.1111/liv.12807

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  37 in total

Review 1.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

2.  HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy.

Authors:  Geoffrey Dusheiko; Bo Wang; Ivana Carey
Journal:  Hepatol Int       Date:  2016-05-31       Impact factor: 6.047

3.  NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.

Authors:  Peifeng Ruan; Jing Shen; Regina M Santella; Shuigeng Zhou; Shuang Wang
Journal:  Nucleic Acids Res       Date:  2016-06-14       Impact factor: 16.971

4.  Hepatitis B Core Antibody Positivity Associated with Increased Risk of Liver Cancer in Patients with Chronic Hepatitis C: Analysis of a Large Patient Cohort in Hawai'i.

Authors:  Olivia A Collis; Patrycja A Ashley; Li-Hsieh Chen; Kathryn L Pedula; Shelley M Miyashiro; Shellie K Yamashita
Journal:  Hawaii J Health Soc Welf       Date:  2022-05

Review 5.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 6.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.

Authors:  Guifang Yu; Xuezhu Chen; Shudi Chen; Weipeng Ye; Kailian Hou; Min Liang
Journal:  J Transl Med       Date:  2016-05-05       Impact factor: 5.531

Review 8.  Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 9.  Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma.

Authors:  Selena Y Lin; Adam Zhang; Jessica Lian; Jeremy Wang; Ting-Tsung Chang; Yih-Jyh Lin; Wei Song; Ying-Hsiu Su
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.